
Nordic Nanovector has recruited a new chief medical officer (CMO) and Executive Management Team member with the appointment of Dr …
Novartis are said to be eyeing a deal for Amneal pharmaceuticals in order to bolster its Sandoz generics business. Bloomsberg …

Celgene has unveiled new data on its selective inhibitor of phosphodiesterase 4 (PDE4) Otezla (apremilast) which shows that the treatment …

AbbVie released details on their latest trials for their investigational, pan-genotypic regimen of glecaprevir (ABT-493)/pibrentasvir (ABT-530). In an eight week …
Novartis has claimed that its Cosentyx (secukinumab) treatment is now the first approved fully human interleukin-17A (IL-17A) inhibitor to demonstrate …

The Teva-Rimsa debacle continues to rumble on, with Teva’s plant in Mexico not producing any drugs for market. The plant …

Allergan announced that Adriana M. Brown will join its board of directors on February 2017. Adriana Brown is currently the …

Pharmafocus, alongside PrimeVigilance, hosted a webinar on 10 November and is now available to view for free.Throughout the webinar, PrimeVigilance …

A number of major drug manufacturers have spoken out against German government plans to cap prescription drug pricing in the …

Mereo BioPharma, a UK-based biopharmaceutical company, has announced that Richard CM Jones has been appointed chief financial officer of the …

The US FDA has granted Priority Review status to Novartis’ experimental drug PKC412 (midostaurin) as a treatment for advanced systemic …

Pfizer’s drug, Celebrex, has been vindicated as of equivalent safety, or better, than ibuprofen and naproxen, after a 10-year study. …

GlaxoSmithKline, the British drugmaker, has topped the overall ranking of the Access to Medicine Index, which ranks 20 top pharmaceutical …

This week has seen pharmaceutical companies defending their patent protections and host of new collaboration spring up between companies. Read …

Almac Group, a global contract pharmaceutical development and manufacturing organisation, has announced that it will spend £27 million in a …

Bionical, an integrated outsourced specialist to the pharmaceutical, biotechnology and public health industry, has announced the acquisition of Emas Pharma. …

Alexion Pharmaceuticals released a statement that it was to begin conducting an internal investigation into sales practices for Soliris (eculizumb) …

Another major piece of voting news emerged on 9 November, with Proposition 61 voted down by Californian residents, with the …

Arix Bioscience, a Britain-based healthcare and life science company, appointed Franz Humer as a senior independent director on 31 October. …

A High Court ruling that NHS England was legally responsible for preventing the spread of HIV has been upheld when …